NovoCure (N2VC34.SA) Q3 2024 Earnings

25JulConfirmed
Q4 2023
Q1 2024
Q3 2024
-2.59
-2.31
-2.03
-1.75

Details

Expected EPS
-2.2733623367
Actual EPS
-1.749361
Surprise EPS
0.52
Surprise Percent
+23.05%

Description

NovoCure (N2VC34.SA) has reported earnings of -1.749361 per share for Q3 2024.

0 Comments

Share your thoughts